Literature DB >> 24289607

Risk factors for cholangiocarcinoma in the lower part of Northeast Thailand: a hospital-based case-control study.

Mereerat Manwong1, Nopparat Songserm, Supannee Promthet, Keitaro Matsuo.   

Abstract

BACKGROUND: Cholangiocarcinoma (CCA) is the most common cancer in Northeast Thailand. It is also a crucial health problem for Thai people. Various risk factors for CCA have been identified in the upper part of Northeast Thailand, but no similar studies of risk factors have been conducted in the lower parts of the region. This study aimed to investigate factors associated with CCA in the resident population.
MATERIALS AND METHODS: A hospital-based case-control study was conducted during 2009-2012 with the recruitment of 123 CCA cases and 123 non-CCA patient controls, matched for sex, age and residential area. Information was collected by interview with a structured questionnaire. Blood samples were collected for assays of anti-OV antibodies. Associations between various personal factors, dietary habits, family history, the presence of anti-OV antibodies and CCA were analyzed using multiple conditional logistic regression.
RESULTS: Patients who consumed raw meat (beef, pork) and alcoholic beverages ≥3 times per week had a higher risk of CCA than non-consumers (ORadj=4.33; 95%CI=1.14-16.35 and ORadj=2.13; 95%CI=1.00-4.55, respectively). Patients who had a family history of cancer had a higher risk than those who did not (ORadj=4.34; 95%CI=1.80-10.43). Also, patients who had anti-OV antibodies (AU>23.337) had a higher risk than those whose anti-OV antibodies were below the cut-off (AU≤23.34) (ORadj=3.09; 95%CI=1.04-9.16).
CONCLUSIONS: As is the case in the upper part of Northeast Thailand, OV infection is a crucial risk factor for CCA in people who live in lower part of the region. Similarly, a family history of cancer and the consumption of alcohol are risk factors for CCA.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24289607     DOI: 10.7314/apjcp.2013.14.10.5953

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  10 in total

Review 1.  Genetic and environmental determinants of risk for cholangiocarcinoma in Thailand.

Authors:  Masanao Miwa; Satoshi Honjo; Gyokukou You; Masakazu Tanaka; Kazuhiko Uchida; Petcharin Srivatanakul; Thiravud Khuhaprema; Watcharin Loilome; Anchalee Techasen; Chaisiri Wongkham; Temduang Limpaiboon; Puangrat Yongvanit; Sopit Wongkham
Journal:  World J Gastrointest Pathophysiol       Date:  2014-11-15

2.  Family History of Cancer and Risk of Biliary Tract Cancers: Results from the Biliary Tract Cancers Pooling Project.

Authors:  Alison L Van Dyke; Margaret S Langhamer; Bin Zhu; Ruth M Pfeiffer; Demetrius Albanes; Gabriella Andreotti; Laura E Beane Freeman; Andrew T Chan; Neal D Freedman; Susan M Gapstur; Graham G Giles; Francine Grodstein; Linda M Liao; Juhua Luo; Roger L Milne; Kristine R Monroe; Marian L Neuhouser; Jenny N Poynter; Mark P Purdue; Kim Robien; Catherine Schairer; Rashmi Sinha; Stephanie Weinstein; Xuehong Zhang; Jessica L Petrick; Katherine A McGlynn; Peter T Campbell; Jill Koshiol
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2018-01-16       Impact factor: 4.254

Review 3.  Association between Liver Fluke Infection and Hepatobiliary Pathological Changes: A Systematic Review and Meta-Analysis.

Authors:  Jing Xia; Shi-chen Jiang; Hong-Juan Peng
Journal:  PLoS One       Date:  2015-07-17       Impact factor: 3.240

Review 4.  Thinking beyond Opisthorchis viverrini for risk of cholangiocarcinoma in the lower Mekong region: a systematic review and meta-analysis.

Authors:  Jennifer A Steele; Carsten H Richter; Pierre Echaubard; Parichat Saenna; Virginia Stout; Paiboon Sithithaworn; Bruce A Wilcox
Journal:  Infect Dis Poverty       Date:  2018-05-17       Impact factor: 4.520

Review 5.  Risk Factors for Cholangiocarcinoma in Thailand: A Systematiczzm321990Review and Meta-Analysis

Authors:  Siriporn Kamsa-ard; Supot Kamsa-ard; Vor Luvira; Krittika Suwanrungruang; Patravoot Vatanasapt; Surapon Wiangnon
Journal:  Asian Pac J Cancer Prev       Date:  2018-03-27

6.  Detection of Risk Groups for Carcinogenic Liver Fluke Infection by Verbal Screening Questionnaire Using a Mobile Application

Authors:  Natthawut Kaewpitoon; Soraya J Kaewpitoon; Thirayu Meererksom; Siwawich Chan-Aran; Wararat Sangwalee; Jirawoot Kujapun; Jun Norkaew; Jirayut Chuatanam; Sukanya Ponpimai; Mali Pothipim; Natnapa Padchasuwan; Taweesak Tongtawee; Likit Matrakool; Sukij Panpimanmas; Ryan A Loyd; Parichart Wakkhuwatthapong
Journal:  Asian Pac J Cancer Prev       Date:  2018-07-27

7.  Opisthorchiasis with proinflammatory cytokines (IL-1β and TNF-α) polymorphisms influence risk of intrahepatic cholangiocarcinoma in Thailand: a nested case-control study.

Authors:  Supannee Promthet; Nopparat Songserm; Somkiattiyos Woradet; Chamsai Pientong; Tipaya Ekalaksananan; Surapon Wiangnon; Akhtar Ali
Journal:  BMC Cancer       Date:  2018-08-23       Impact factor: 4.430

8.  Association between periductal fibrosis and bile duct dilatation among a population at high risk of cholangiocarcinoma: a cross-sectional study of cholangiocarcinoma screening in Northeast Thailand.

Authors:  Nittaya Chamadol; Narong Khuntikeo; Bandit Thinkhamrop; Kavin Thinkhamrop; Apiporn T Suwannatrai; Matthew Kelly; Supannee Promthet
Journal:  BMJ Open       Date:  2019-03-20       Impact factor: 2.692

9.  Cholangiocarcinoma protective factors in Greater Mekong Subregion: Critical issues for joint planning to sustainably solve regional public health problems.

Authors:  Nopparat Songserm; Somkiattiyos Woradet; Waratip Kankarn; Kanjanar Pintakham; Phouthong Vanhnivongkham; Nguyen Thi To Uyen; Nguyen Cong Cuu; Le Ngoc Cua; Banchob Sripa; Akhtar Ali
Journal:  PLoS One       Date:  2022-01-27       Impact factor: 3.240

10.  Association between praziquantel treatment and cholangiocarcinoma: a hospital-based matched case-control study.

Authors:  Supot Kamsa-Ard; Vor Luvira; Ake Pugkhem; Varisara Luvira; Bandit Thinkhamrop; Krittika Suwanrungruang; Vajarabhongsa Bhudhisawasdi
Journal:  BMC Cancer       Date:  2015-10-24       Impact factor: 4.430

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.